The Cell-Based Assays Market is projected to grow from $35.3 billion in 2024 to $56.3 billion by 2029, at a 9.8% CAGR, driven by demand for drug discovery, ADME/toxicity testing, and precision ...

Built upon CN Bio’s human-derived and highly characterized liver microphysiological system (MPS), the DILI assay kit provides robust, human-relevant insights into crucial drug safety parameters ...

Drug testing is a complex process, with heart toxicity assessment being a crucial step. Traditionally, this involved animal ...

The global Stem Cell Assays Market is experiencing unprecedented growth, driven by advancements in regenerative medicine, ...

The predictive capability of the platform—including forecasting drug efficacy, toxicity and mode of action ... a nine-marker clinical flow-cytometry assay that outperforms all existing assays ...